Introduction: The word dystrophy comes from Latin and Greek roots meaning “faulty eating plan.” When doctors first began describing muscle diseases while in the 19th century, they had few tools other their own eyes. Muscular tissues in many diseases appeared to be losing away, and the doctors theorized they somehow weren’t being properly Fed. Today, we know that many muscle tissue wasting diseases are caused by blemishes in genes for the muscle tissue proteins. Most of these proteins manage to play a role in supporting the structure of muscle fibers, although some necessary protein may play a role in the biochemical processes built on inside the muscle fibers. The idea of Muscular dystrophy refers to a group of inherited diseases marked by accelerating weakness and degeneration from the skeletal or voluntary muscles, that control movement. The muscle tissues of the heart and some additional involuntary muscles are also influenced in some forms of muscular dystrophy, and several forms involve other body parts as well. The major forms of muscle bound dystrophy are myotonic, Duchenne, Becker, limb-girdle, facioscapulo-humeral, congenital, oculo-pharangeal, distal and Emery-Dreifuss. Some of these names are based on the spots of affected muscles. Such as, “facioscapulo-humeral” refers to the muscles that shift the face, scapula (shoulder blade) as well as humerus (upper arm bone). Others are based on the type of muscle trouble involved (“myotonic” means difficulty relaxing muscles), the age of onset of the infection (as in “congenital,” or birth-onset, dystrophy), or perhaps the doctors who first identified the disease (Duchenne, Becker, Emery and Dreifuss are doctors’ companies). Forms of muscular dystrophy differ around severity, age of onset, muscles first and most often influenced, the rate at which symptoms advance, and the way the disorders will be inherited. The muscular dystrophy will be diagnosed by muscle biopsy, DNA testing, electromyogram (E M G) and nerve conduction velocity (Deborah C V). Blood chemical tests are helpful because degenerating muscle become “leaky”. They leak digestive enzymes, which can then be diagnosed in the blood. Presence of those enzymes in the blood on higher than normal levels is a sign of muscular dystrophy. One such enzyme is usually Creatine kinase, or CK. The CK place is elevated in many styles of muscular dystrophy, some forms providing a higher level than others. Duchenne muscular dystrophy (DMD) is among the most common lethal X-linked recessive disorder, impacting 1 in 3,500 live guy births (1). DMD children show quick symptoms of muscle degeneration, generally develop contractures, and lose the ability walking between 6 and 12 years of age. With progressive ailment, most patients succumb to death from respiratory failure in addition to cardiac dysfunction in their twenties (2). The primary cause of this disease is a result of mutations in the dystrophin gene, which is essential for the structural and well-designed integrity of muscles (Several). Mutations in dystrophin result in tissue layer damage, allowing massive infiltration connected with immune cells, chronic redness, necrosis, and severe muscle weakening (2). Normally, muscle solar cells possess the capacity to regenerate in answer to injury signals. Nevertheless, this ability is displaced in DMD, presumably due to the exhaustion of satellite solar cells during ongoing degeneration in addition to regeneration cycles (1). While dystrophin mutations represent the primary reason for DMD, it is the secondary processes relating to persistent inflammation and disadvantaged regeneration that likely aggravate disease progression. DMD is seen as (i) Onset of muscle weak point usually before 4 years of age, (ii) Selective muscle effort of pelvic and pectoral girdles, (iii) Hypertrophy from the calves muscle, (iv) really elevated serum C K amounts and (v) Relentlessly gradual weakness of muscle, ultimately causing inability to work within Few years of onset and later to help contractures and thoracic deformity. There is no specific cure in any system of medicine and the death usually takes place before the age of 20 years the result of respiratory failure or less often by cardiac involvement.(Five) Becker muscular dystrophy (BMD) was initially described by Becker as well as Kiener in 1955.(5, 7). The signs, symptoms and the length of Becker muscular dystrophy (BMD) are similar to those of Duchenne nonetheless generally appear later and progress more slowly. BMD is generally docile than DMD. The clinical distinction between the 2 conditions is actually easy because (i) more gentle muscle weakness is witnessed in patients with BMD and (2) affected maternal uncles with BMD stay ambulatory after age 15-20 years. Precision of diagnosis has been polished with the recognition of the dystrophin gene blemishes and with dystrophin staining of muscle tissue biopsy specimens.(3, 4, 5). The Becker dystrophy can first seem to be much later than Duchenne, even as later as age 25. The progression is typically slower, web site walk usually preserved in the 30s. The severity of the disease differs, and boys and males with Becker dystrophy have a longer life requirement than those with Duchenne. The continuing development of weakness depends on how much dystrophin is done and how well it functions in the muscles. Limb-girdle muscular dystrophies (L G M D) are neuromuscular issues characterized by proximal muscular weakness on the pelvic and shoulder girdles and a diverse progression with symptoms, ranging from very severe to mild (Several), (4). The onset of Arm or leg Girdle Muscular dystrophy (L G Mirielle D) is generally in puberty or early adulthood. For most common forms, L H M D causes modern weakness that starts from the hips and moves to your shoulders. The weakness progresses to include the arms and legs. Within just 20 years of onset, jogging is difficult. Researchers have found that autosomal recessive limb-girdle dystrophy might occur from gene defect on chromosomes Only two, 13, 15, and 17, and that an autosomal dominant style can result from gene defects for chromosome 5. A gene on chromosome 17 that codes for the enzyme calpain 3 may also play a role in some cases of L G M D. Pathogenesis: Dystrophy is a genetic problem and is caused by lack of an individual muscle protein Dystrophin (1 involving 3000 muscle proteins). DMD as well as BMD are due to different changes in the dystrophin gene, which contains information for a healthy proteins that is important for muscle tissue to work properly. This gene is located on the X chromosome. Dystrophin is local to the sarcolemma in normal skeletal muscles, but is completely absent within muscle from DMD patients (Seven). Usually disease is inherited although is also caused by spontaneous mutation above 30% of the time. Each child with the carrier mother has a 50% chance of inheritance of Muscular dystrophy. Although girls can be carriers, more than 80% show no muscular dystrophy linked symptoms. At present a speculation postulates a defect in the sarcolemma membrane layer which allows a substance (or chemicals), as yet unknown but which often can possibly be calcium, to enter the muscles fiber too freely, and there to activate neutral proteases which, in turn, maintain an increased degree of muscle catabolism and result in muscle fiber necrosis. (9, Twelve, 11, 12). No therapy for this is at present known in any method of medicine which has any certain influence upon muscular dystrophy. The absence of specific treatment for muscular dystrophy makes it all the more important to consider supporting and alternative approaches connected with treatment. In India, your Dystrophy boys always seek Ayurvedic assist in the hope for some relief. The Ayurvedic treatment involving Rasayana group of herbo-mineral as well as gold based medicine, yogic support and specific Panch karma procedures show definite protective influence and also longer survival upon muscle bound dystrophy. Ayurvedic Acharyas carefully consider this condition as adibala-pravrit Mamsa-vata-kshaya as a result of srotorodha. There is depletion of Mamsagni introducing the way of Ama formation. It is as well as vitiation of Kapha dosha. (13, 14, 15). While srotorodha produces hypertrophy in particular location, it also manifests as primary prokopa and then depletion of Vata component. This complex pathogenesis is responsible for accelerating wasting and necrosis of the afflicted muscle fibers. Ayurveda visualizes 13 major sorts of Agnis (enzyme complex) which are liable for the process of metabolism. Each of several dhatus has individual dhatvagnis. The increase or even decrease of a particular dhatus depends upon the increase or decrease of respective dhatvagnis. As outlined by Charak, Mamsa-kshaya may be present when there is prolonged majjagata kupita Vata. This is always followed by destruction of Vata element. It is inherited predisposition (Beeja dosha) that convert biological Vata element in to pathological morbidity. The actual srotodushti (? Sarcolemma membrane defect) is responsible for the mamsa dhatu kshaya. The concept of Dosha-Dhatu-Mala (D. D. Mirielle) is unique in Ayurveda. The dhatus are substances which are retained from the body and always rejuvenated and also replenished. Ras-Rakta-Mamsa-Meda-Asthi-Majja and Sukra are eight dhatus which develops in overall body in a fixed, sequential approach one from the other. Each one succeeding dhatu is a metabolic refinement with the previous dhatu and get nourished by it. The first dhatu, Rasa (nutrient fluid) could be the metabolic end product of the digestive system that takes place within gastro-intestinal pathway. The Rasa dhatu has to be metabolized in Rakta dhatu. The Mamsa dhatu comes from Rakta dhatu and in turn, give rise to Meda dhatu. The Asthi dhatu is the product with Meda dhatupaka that contains Majja dhatu which is the prime hold of Vata element. (13, 17) We know that Vata (Prana) and Rakta dhatu tend to be two major life keeping elements in the body. The Vata has been attributed like genetic fabric that carries life data essential for different activities. This Rakta dhatu is the basis of biological power that provides nutrition at mobile level and paves the way involving excretion of metabolic toxins. The particular driving force beyond Rakta dhatu is Vata element which circulates itself to cellular level along with Rakta. This conjoint circulation of both Rakta along with Vata is manifestation of life (Prana). This particular Prana is responsible for the contraction along with relaxation of muscle fibers or perhaps muscular activity. It means we have to focus our attention around the dhatvagnis paka of Rasa-Rakta-Mamsa and Meda dhatus besides Asthi as well as Majja dhatus. In this context Ayurvedic Rasayana therapy has significant role to play. (Sixteen, 17) Ancient Ayurvedic physicians had developed certain dietary and healing measures to arrest/delay degeneration process and rejuvenating whole well-designed dynamics of the body system. This revitalization and rejuvenation is known as your ‘Rasayana Chikitsa’ (rejuvenation therapy). Rasayana are particular ayurvedic resources that increase enzymatic essence of each dhatu starting from Rasa dhatu. Ayurveda uses plant based mineral and metallic supply for this purpose. Traditionally, Rasayana drugs are made use of against a plethora of seemingly varied disorders with no patho-physiological connections in accordance with modern medicine. Though, this group of plants generally possesses robust antioxidant activity, only a few are investigated in detail. Neurodegenerative diseases are actually reported as reactive oxygen type mediated and several Rasayana plants with strong antioxidant activity have been reported by many investigators (18). The actual pure gold bhasma in small dose has been used successfully inside management of degenerative diseases of mamsa along with Majja dhatu. (19, 20, 21). Particular Ayurvedic herbs known for their Rasayana effects have been scientifically verified for their feasible effect in the management of Muscle dystrophy. The well known herb Curcuma longa has become widely investigated for the immuno-localization and activation of nuclear factor-